No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
AVTE Aerovate
- 1.780
- -0.040-2.20%
Close Jul 19 16:00 ET
51.30MMarket Cap-587P/E (TTM)
1.880High1.770Low250.51KVolume1.830Open1.820Pre Close456.60KTurnover2.46%Turnover RatioLossP/E (Static)28.82MShares32.41552wk High0.56P/B18.11MFloat Cap1.25052wk Low--Dividend TTM10.17MShs Float32.415Historical High--Div YieldTTM6.04%Amplitude1.250Historical Low1.822Avg Price1Lot Size
Pre-Market
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Aerovate Therapeutics Shares Are Trading Higher After the Company Announced It Is Exploring Strategic Alternatives
Express News | Aerovate Therapeutics To Explore Strategic Alternatives Which May Include But Are Not Limited To, An Acquisition, Merger, Reverse Merger, Business Combination, Liquidation Or Other Transaction
Express News | Aerovate Therapeutics - Wedbush Pacgrow Engaged as Exclusive Advisor
Express News | Aerovate Therapeutics Inc - to Conduct Strategic Alternatives Review
Express News | Aerovate Therapeutics to Explore Strategic Alternatives
Aerovate's Catastrophic Year: Failed PAH Drug Trial Leads To Mass Layoffs
Comments
$Aerovate(AVTE.US$ Aerovate Therapeutics To Explore Strategic Alternatives Which May Include But Are Not Limited To, An Acquisition, Merger, Reverse Merger, Business Combination, Liquidation Or Other Transaction
$Aerovate(AVTE.US$ Mass layoffs 😯
2
1
$Aerovate(AVTE.US$ is ready to pop too.
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg